Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is used to support cognitive function and is prescribed for conditions such as cognitive impairment, dementia, dyslexia, myoclonus and vertigo in adults. GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Piracetam, a racetam nootropic, is employed in several neurological and cognitive disorders.

- Cognitive impairment: may improve attention, memory and learning performance. - Dementia: may support cognitive stability and daily functioning. - Dyslexia: may aid reading skills and language processing. - Myoclonus: may reduce involuntary muscle jerks. - Vertigo: may alleviate balance disturbances.

Adverse reactions to piracetam are generally mild, but monitoring is advised.

Common Side Effects: - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: occasional gastrointestinal discomfort. - Anxiety: feelings of nervousness or restlessness. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Depression: emergence or worsening of depressive symptoms. - Allergic reactions: rash, itching, or swelling. - Blood disorders: rare cases of thrombocytopenia or leukopenia. - Seizures: rare exacerbation in predisposed individuals. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing piracetam, consider the following safety measures.

- Renal function: assess before initiating therapy. - Elderly patients: monitor for confusion or falls. - Pregnancy: use only if clearly needed after risk assessment. - Breastfeeding: evaluate potential exposure to the infant. - Concomitant CNS depressants: use with caution due to additive effects. - Store at room temperature: keep in the original pack, protect from moisture.

Piracetam may interact with several drug classes; awareness of interaction severity helps guide safe use.

Major Interactions (Avoid): - Anticonvulsants: may reduce seizure‑control efficacy. - Anticoagulants: potential increase in bleeding risk. - Alcohol: may enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Caffeine: may increase stimulation and anxiety. - Diuretics: may alter plasma concentrations. - Other racetams: additive cognitive effects may occur. - CNS stimulants: may potentiate excitatory symptoms. - Herbal supplements (e.g., ginkgo): monitor for synergistic effects.